ADVM: Adverum Biotechnologies, Inc. Stock

by  •  • Comments Off on ADVM: Adverum Biotechnologies, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 119.61
Enterprise Value ($M) 26.76
Book Value ($M) 144.12
Book Value / Share 6.93
Price / Book 0.83
NCAV ($M) 70.82
NCAV / Share 3.40
Price / NCAV 1.69

Profitability (mra)
Return on Invested Capital (ROIC) -0.43
Return on Assets (ROA) -0.48
Return on Equity (ROE) -0.92

Liquidity (mrq)
Quick Ratio 5.82
Current Ratio 5.82

Balance Sheet (mrq) ($M)
Current Assets 161.08
Assets 234.38
Liabilities 90.26
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
11-14 13G/A Vivo Opportunity Fund Holdings, L.P. 1.10 -98.54
11-14 13G/A Commodore Capital Lp 0.00 -100.00
11-14 13G/A Logos Global Management LP 2.00 -97.22
11-12 13G/A Fmr Llc 1.13 -96.17
11-08 13G BlackRock, Inc. 7.20 0.00
11-06 13G/A Morgan Stanley 0.40 -98.47
10-30 13G Stern Augustus 5.37
10-23 13G Principia Wealth Advisory, LLC 5.07
07-22 13G/A BML Investment Partners, L.P. 10.60 93.37
05-14 13D/A Versant Ventures IV, LLC 2.40 -90.00
02-15 13G TCG Crossover GP II, LLC 9.90
02-14 13G/A Venrock Healthcare Capital Partners III, L.P. 7.50 163.82
02-13 13G/A Bank Of America Corp /de/ 4.40 -20.85
02-09 13G Frazier Life Sciences Public Fund, L.P. 5.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-04 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-03-18 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K _______________________________________________________________________________ ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-11-22 67,269 411,564 16.34
2024-11-21 128,319 844,308 15.20
2024-11-20 55,535 204,730 27.13
2024-11-19 124,716 603,842 20.65
2024-11-18 100,757 356,493 28.26

(click for more detail)

Similar Companies
ACXP – Acurx Pharmaceuticals, Inc. ADIL – Adial Pharmaceuticals, Inc.
ADTX – Aditxt, Inc. AGEN – Agenus Inc.
AIMD – Ainos, Inc.


Financial data and stock pages provided by
Fintel.io